Drug has been used off-label for weight loss leading to a global shortage and usage may come with risks, experts say
Get our morning and afternoon news emails, free app or daily news podcast
Australia’s drug regulator is investigating new reports of potential gastro-intestinal side effects of diabetes turned weight-loss drug Ozempic.
Ozempic, is a drug prescribed as a treatment for type 2 diabetes, but has been widely used off-label for weight loss, causing worldwide shortages, including in Australia. The same drug, branded as Wegovy, is now approved for weight management in Australia, but is not currently available.
About Author
More Stories
Italian government approved use of spyware on members of refugee NGO, MPs told
Export of endangered eels to Russia ends after UK government ban
Flight bookings between Canada and US down 70% amid Trump tariff war